CR-R10
ReferenceCompany-reported
Neuralink: 21 trial participants; "zero serious device-related adverse events" so far.
- Claim made
- Who
- Neuralink
- Target date
- —
- Status checked
- 28 September 2026
Source
neuralink.com [F]
Evidence to date
Company measurement; no independent or regulatory data checked.
Next indicator
Independent or regulatory safety data